Science
Mechanism of Action
This peptide is derived from a synthesized copy of the human gene encoding nerve growth factor beta (NGF-β). However, detailed insights into its precise mechanism of action on the skin for topical application, and any associated known benefits, are not explicitly outlined in current research.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Safety
Safety Profile
Specific regulatory reviews by bodies such as CIR, SCCS, or FDA are not available for SH-OLIGOPEPTIDE-14. While broader discussions concerning potential mitogenic activity and cancer risks have been raised for other peptides like SH-OLIGOPEPTIDE-1 (EGF), these concerns are not directly attributed to SH-OLIGOPEPTIDE-14 based on current information.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Due to a notable absence of specific clinical studies, a clearly defined topical mechanism of action, and comprehensive safety reviews, the overall efficacy and safety profile of SH-OLIGOPEPTIDE-14 for skincare applications are currently underevaluated.
Related
Similar Ingredients
Finding similar ingredients…